Kessler steps down from the FDA
FDA Commissioner David Kessler, M.D., is leaving after six years at the agency
Distributor, manufacturer merge to form BBI Healthcare
One of the largest drug wholesalers in the United States agreed to merge with a major drug maker known for its generic products.
What experts predict this year
Pharmaceutical Representative recently asked industry experts to predict the future. The following are their responses about the coming year.
Alzheimer's expert is optimistic
More than 4 million people suffer from Alzheimer's disease, according to the Chicago-based Alzheimer's Association. The progressive dementing illness gradually robs its victims of mind, independence and identity.
Guidelines out on psychiatric disorders
Psychiatrists have developed new clinical guidelines for treating bipolar disorder and schizophrenia.
Anticancer vaccine approved
In a significant victory against cancer, FDA has approved the first vaccine developed to prevent cervical cancer,
Supreme Court: Research Use of Patented Compounds OK
We asked top intellectual property lawyers about what the Supreme Courts decision will mean for pharma and biotech companies. Here is our forward-looking analysis of their comments.
